PAPI, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 571
EU - Europa 228
AS - Asia 222
SA - Sud America 4
AF - Africa 3
Totale 1.028
Nazione #
US - Stati Uniti d'America 565
IT - Italia 124
SG - Singapore 103
CN - Cina 68
ID - Indonesia 32
DE - Germania 31
PL - Polonia 15
HK - Hong Kong 12
GB - Regno Unito 11
SE - Svezia 11
FI - Finlandia 9
CA - Canada 5
CZ - Repubblica Ceca 5
FR - Francia 5
NL - Olanda 4
BE - Belgio 3
BR - Brasile 3
VN - Vietnam 3
CH - Svizzera 2
EG - Egitto 2
GR - Grecia 2
LT - Lituania 2
RO - Romania 2
AT - Austria 1
BD - Bangladesh 1
EC - Ecuador 1
ES - Italia 1
MA - Marocco 1
MX - Messico 1
PK - Pakistan 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 1.028
Città #
Santa Clara 84
Singapore 83
Ashburn 60
Chandler 57
Fairfield 46
Ferrara 44
Jakarta 32
Shanghai 31
Seattle 23
Woodbridge 23
Addison 19
Houston 18
Beijing 16
Bremen 16
Cambridge 16
Milan 16
Warsaw 15
Wilmington 15
Hong Kong 12
Princeton 12
Los Angeles 11
Ferrara di Monte Baldo 9
Boardman 8
Munich 8
Bologna 7
Frankfurt am Main 7
Helsinki 7
London 7
San Diego 7
Washington 7
New York 6
Rome 6
Ann Arbor 5
Guarda Veneta 4
Toronto 4
Brno 3
Brussels 3
Cesena 3
Dong Ket 3
Athens 2
Bern 2
Buffalo 2
Crevalcore 2
Hefei 2
Heliopolis 2
Lappeenranta 2
Padova 2
Amsterdam 1
Aquileia 1
Ariano nel Polesine 1
Baricella 1
Bexhill 1
Changsha 1
Chicago 1
Chiswick 1
Curitiba 1
Dearborn 1
Dhaka 1
Guayaquil 1
Hounslow 1
Jiujiang 1
Jundiaí 1
Karachi 1
Langfang 1
Madrid 1
Mexico City 1
Naples 1
Ningbo 1
North Bergen 1
Norwalk 1
Olomouc 1
Ottawa 1
Pacatuba 1
Piscataway 1
Prague 1
Redwood City 1
Reggio Emilia 1
Riyadh 1
Shenyang 1
Stoughton 1
Taicang 1
Verona 1
Vienna 1
Wuxi 1
Totale 806
Nome #
Altered erythroid-related miRNA levels as a possible novel biomarker for detection of autologous blood transfusion misuse in sport 117
Efficient Delivery of MicroRNA and AntimiRNA Molecules Using an Argininocalix[4]arene Macrocycle 85
Demonstrating specificity of bioactive peptide nucleic acids (PNAs) targeting microRNAs for practical laboratory classes of applied biochemistry and pharmacology 76
Circulating microRNAs and liquid biopsy: murine xenograft models for technical validation of clinical protocols 67
Analysis of the miRNome as a possible tool for the detection of autologous blood transfusion misuse in sport 58
A peptide nucleic acid (PNA) masking the miR-145-5p binding site of the 3’UTR of the cystic fibrosis transmembrane conductance regulator (CFTR) mRNA enhances CFTR expression in Calu-3 cells 58
Up-regulation of miR-34a-3p and miR-744-3p is associated with down-regulation of PTEN in lymphoblastoid cells from Shwachman-Diamond Syndrome patients 54
A distinctive microrna (Mirna) signature in the blood of colorectal cancer (crc) patients at surgery 54
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin) 48
509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis 43
A Signature of Differentially Expressed Micrornas in Lymphoblastoid Cells from Shwachman-Diamond Syndrome Patients Indicates Possible Molecular Targets for Mirna Therapeutics 43
Sulforaphane inhibits the expression of interleukin-6 and interleukin-8 induced in bronchial epithelial IB3-1 cells by exposure to the SARS-CoV-2 Spike protein 42
SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation 39
Treatment of Human Glioblastoma U251 Cells with Sulforaphane and a Peptide Nucleic Acid (PNA) Targeting miR-15b-5p: Synergistic Effects on Induction of Apoptosis 38
Combined Treatment of Bronchial Epithelial Calu-3 Cells with Peptide Nucleic Acids Targeting miR-145-5p and miR-101-3p: Synergistic Enhancement of the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene 35
Teaching during COVID-19 pandemic in practical laboratory classes of applied biochemistry and pharmacology: A validated fast and simple protocol for detection of SARS-CoV-2 Spike sequences 35
Effects of Sirolimus treatment on patients with β-Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4+ and CD8+ T cells 33
High Levels of Apoptosis Are Induced in the Human Colon Cancer HT-29 Cell Line by Co-Administration of Sulforaphane and a Peptide Nucleic Acid Targeting miR-15b-5p 31
MicroRNAs miR-584-5p and miR-425-3p Are Up-Regulated in Plasma of Colorectal Cancer (CRC) Patients: Targeting with Inhibitor Peptide Nucleic Acids Is Associated with Induction of Apoptosis in Colon Cancer Cell Lines 25
Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut Microbiota 21
Production and Characterization of K562 Cellular Clones Hyper-Expressing the Gene Encoding α-Globin: Preliminary Analysis of Biomarkers Associated with Autophagy 20
Effects of Sulforaphane on SARS‑CoV‑2 infection and NF‑κB dependent expression of genes involved in the COVID‑19 'cytokine storm' 17
Cationic Calix[4]arene Vectors to Efficiently Deliver AntimiRNA Peptide Nucleic Acids (PNAs) and miRNA Mimics 16
The anti-SARS-CoV-2 BNT162b2 vaccine suppresses mithramycin-induced erythroid differentiation and expression of embryo-fetal globin genes in human erythroleukemia K562 cells 15
The Cystic Fibrosis Transmembrane Conductance Regulator Gene (CFTR) Is under Post-Transcriptional Control of microRNAs: Analysis of the Effects of agomiRNAs Mimicking miR-145-5p, miR-101-3p, and miR-335-5p 14
Liquid biopsy-based colorectal cancer diagnosis: analysis of a limited panel of miRNA in mice bearing colorectal carcinoma tumor xenografts and in Human plasma samples 13
Aged Garlic Extract (AGE) and Its Constituent S-Allyl-Cysteine (SAC) Inhibit the Expression of Pro-Inflammatory Genes Induced in Bronchial Epithelial IB3-1 Cells by Exposure to the SARS-CoV-2 Spike Protein and the BNT162b2 Vaccine 2
Totale 1.099
Categoria #
all - tutte 10.857
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.857


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202063 0 0 0 0 0 0 6 7 20 14 13 3
2020/202192 7 2 9 3 6 7 5 10 8 21 7 7
2021/2022142 11 7 18 4 5 2 22 5 11 4 15 38
2022/2023194 14 31 4 16 28 8 32 11 19 3 13 15
2023/2024245 8 20 19 13 29 49 9 28 4 2 5 59
2024/2025344 29 20 83 58 82 57 15 0 0 0 0 0
Totale 1.099